Aug 2026· Comprehensive Physiology· 0 citations· 55 references
TL;DR
Thrombospondin 1 regulates pathological interorgan communication between GC cells and the peritoneal niche by targeting TAMs through metabolic reprogramming, thereby providing a potential therapeutic target for GC with PM and insights into interorgan metastasis mechanisms.
Abstract
This study aimed to identify the role of thrombospondin 1 (THBS1) in gastric cancer (GC) with peritoneal metastasis (PM) as a model of aberrant interorgan communication between gastric carcinoma and the peritoneal microenvironment.
Bulk, single‐cell, and spatial transcriptomics were performed to identify mechanisms underlying M2 macrophage‐mediated GC with PM. RNA immunoprecipitation confirmed binding between RNA‐protein and GC9811‐P cells. A GC9811‐P‐tumor‐associated macrophage (TAM) co‐culture system was established. Macrophage polarization markers were performed after THBS1 knockdown, using cell counting kit‐8, flow cytometry, migration and invasion assays, and glucose/lipid metabolism detection. Meanwhile, an enzyme‐linked immunosorbent assay was performed to measure inflammatory factors. In vivo, a BALB/C GC peritoneal dissemination mouse model was employed to investigate the regulatory role of THBS1 in GC with PM progression.
Transcriptomic analysis identified SEMA7A, THBS1, and HBEGF as key mediators of intercellular communication between M2 macrophages and malignant cells, with RIP assay confirming the targeted binding of THBS1 to SDC4. THBS1 knockdown suppressed GC9811‐P cell proliferation, migration, and invasion; inhibited M2 polarization; and reduced mitochondrial membrane potential, ATP levels, and HIF‐1ɑ, PFKFB3, ABHD5, and MGLL expression. In vivo, THBS1 knockdown reduced peritoneal metastatic tumor burden.
THBS1 regulates pathological interorgan communication between GC cells and the peritoneal niche by targeting TAMs through metabolic reprogramming, thereby providing a potential therapeutic target for GC with PM and insights into interorgan metastasis mechanisms.
WNK4 acts as an immune-relevant suppressor in endometrial cancer, partly by limiting M2-like polarization and weakening macrophage-driven tumor support, partly by limiting M2-like polarization and weakening macrophage-driven tumor support.
It is suggested that GNAS-AS1 may contribute to the maintenance of M2-like characteristics in TAMs and facilitate CC progression, potentially through a mechanism involving miR-518c-5p sequestering, FBXO38 upregulation, and subsequent modulation of MAPK signaling.
Li-Li Zhang, Fang Zhao, Lin Zhang et al.· Molecular Carcinogenesis· 0 citations
Current evidence on TAM‐driven chemoresistance in GC is synthesized, highlighting the molecular interplay between TAMs, tumor cells, and stromal components and underscores the potential of TAM‐centric therapies to overcome resistance and improve clinical outcomes.
S. Abdul-Rahman, Abdulkareem Shareef, S. Jyothi et al.· Cell Biology International· 0 citations
It is indicated that FSTL1 represents a promising immunomodulatory target and highlight its potential as a therapeutic target to reprogram the immunosuppressive microenvironment and improve the efficacy of GC immunotherapy.
Ming Yang, Rong-Fei Wang, Xiao Wang et al.· Journal of Translational Med...· 0 citations
ABSTRACT Coagulation factor VII (F7) has been implicated in tumor progression; however, its role in gastric cancer metastasis and immune evasion remains incompletely understood. In this study, we identified F7 as a clinically relevant driver of gastric cancer. F7 was highly expressed in tumor tissues and closely associ...
Lei Gao, Qin-Ying Han, Yunpeng Wang et al.· Advancement of science· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.